A “Latex-Free” Laparoscopy Pack Contained Latex. Here's Why That Matters.

When a surgical pack is labeled “latex-free,” the OR team should be able to trust that label.

A recent FDA recall raises questions about what happens when the contents of a surgical kit don't match the information printed on its packaging.

What Happened?

On August 26, 2026, GRI Medical & Electronic Technology initiated a recall involving certain HALYARD Laparoscopy Comprehensive Pack II kits.

The FDA posted the Class II recall on October 2.

According to the agency, the packs were labeled “latex free” but contained a latex urethral catheter.

The affected product was identified as reference number 49332, involving three specific lots.

The FDA listed 396 kits in commerce and identified distribution in Mississippi.

Customers were instructed to segregate affected inventory, stop distribution and transfers, document affected quantities, and notify appropriate personnel.

Why It Matters to Surgical Professionals

A surgical pack is designed to simplify preparation.

Instead of gathering every supply individually, teams can rely on a collection of products assembled for a particular procedure.

But convenience also creates dependence on accurate product labeling and reliable component selection.

For patients with latex sensitivity or allergy, incorrect labeling can create an exposure concern.

And for the OR team, the issue may not be obvious from the outer packaging.

That's what makes this recall particularly important.

The package label and the package contents did not agree.

The Bigger Lesson About Surgical Packs

Preassembled kits can support efficiency, consistency, and preparation.

However, they also connect multiple parts of the supply chain.

A problem with one component can affect an entire pack.

This is why product recalls require coordination among purchasing, supply chain, perioperative leadership, and frontline teams.

The challenge isn't simply identifying the recalled product.

It's ensuring affected packs are removed from circulation before they reach the surgical suite.

The FTLOS Takeaway

A label is a safety communication tool.

When labeling is inaccurate, the consequences can extend beyond inventory management.

This recall is a reminder that surgical professionals rely on accurate information from manufacturers and suppliers—and that recall systems must be capable of correcting that information when problems are discovered.

Join the Conversation

Have you ever encountered a surgical pack containing an unexpected or incorrect component?

Share lessons about processes and communication, without identifying patients or facilities.

U.S. Food and Drug Administration. “Class 2 Device Recall HALYARD Laparoscopy Comprehensive Pack II.” FDA Medical Device Recalls, 2 Oct. 2026, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=222520.